Skip to content

Author

Parastoo Hassani-Abharian

We have 1 of 3 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Profiling fungal secondary metabolites with anti-leishmanial activity: an integrated in silico and in vitro study.

Dihydrocitrinone's promising antileishmanial potency provides a suitable scaffold for medicinal chemistry optimization and the development of novel therapeutics for leishmaniasis and highlights the underexplored potential of fungal SMs in antileishmanial drug discovery.

Parastoo Hassani-Abharian, M. Ghanadian, A. Fassihi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.